BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32228151)

  • 21. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
    Spencer C; Petrovic I; Fatemi S; LoPresti J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.
    Morbelli S; Ferrarazzo G; Pomposelli E; Pupo F; Pesce G; Calamia I; Fiz F; Clapasson A; Bauckneht M; Minuto M; Sambuceti G; Giusti M; Bagnasco M
    J Endocrinol Invest; 2017 Apr; 40(4):417-424. PubMed ID: 27844413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome.
    Trimboli P; Zilioli V; Imperiali M; Giovanella L
    Clin Chem Lab Med; 2017 Oct; 55(12):1995-2001. PubMed ID: 28467308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; MarinĂ³ M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer.
    Reverter JL; Rosas-Allende I; Puig-Jove C; Zafon C; Megia A; Castells I; Pizarro E; Puig-Domingo M; Granada ML
    J Thyroid Res; 2020; 2020():8312628. PubMed ID: 32351680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
    Dekker BL; van der Horst-Schrivers ANA; Sluiter WJ; Brouwers AH; Lentjes EGWM; Heijboer AC; Muller Kobold AC; Links TP
    Thyroid; 2019 Jan; 29(1):71-78. PubMed ID: 30351209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer.
    Herman AE; Argersinger DP; Maksutova M; Morgan T; Hughes DT
    Endocr Pract; 2024 Feb; 30(2):89-94. PubMed ID: 37926368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
    Verburg FA; Luster M; Cupini C; Chiovato L; Duntas L; Elisei R; Feldt-Rasmussen U; Rimmele H; Seregni E; Smit JW; Theimer C; Giovanella L
    Thyroid; 2013 Oct; 23(10):1211-25. PubMed ID: 23692026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
    Seo JH; Lee SW; Ahn BC; Lee J
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):558-63. PubMed ID: 19744107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; MarinĂ² M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroglobulin antibodies in differentiated thyroid cancer.
    Hjiyiannakis P; Mundy J; Harmer C
    Clin Oncol (R Coll Radiol); 1999; 11(4):240-4. PubMed ID: 10473720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer.
    Smooke-Praw S; Ro K; Levin O; Ituarte PH; Harari A; Yeh MW
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):271-5. PubMed ID: 24494778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
    Ozkan E; Soydal C; Araz M; Aras G; Ibis E
    Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroglobulin antibody resolution after total thyroidectomy for cancer.
    Xu J; Bergren R; Schneider D; Chen H; Sippel RS
    J Surg Res; 2015 Oct; 198(2):366-70. PubMed ID: 25930167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.